SLC30A8 and type 1 diabetes mellitus: Although, ZnT8-ab are reported in the majority of T1DM patients prior to and at clinical diagnosis, the relationship between the presence of ZnT8-ab and severity of the initial clinical manifestation remains ambiguous.